Verastem Price To Book vs. EBITDA

VSTM Stock  USD 4.00  0.07  1.78%   
Taking into consideration Verastem's profitability measurements, Verastem may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Verastem's ability to earn profits and add value for shareholders. At this time, Verastem's Price To Sales Ratio is very stable compared to the past year. As of the 25th of November 2024, Price Sales Ratio is likely to grow to 35.54, while Days Sales Outstanding is likely to drop 3.73. At this time, Verastem's Accumulated Other Comprehensive Income is very stable compared to the past year. As of the 25th of November 2024, Total Other Income Expense Net is likely to grow to about 5 M, while Income Before Tax is likely to drop (91.7 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.951.1
Fairly Down
Pretty Stable
For Verastem profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Verastem to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Verastem utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Verastem's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Verastem over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.14)
Revenue Per Share
0.331
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.47)
Return On Equity
(1.37)
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Verastem EBITDA vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Verastem's current stock value. Our valuation model uses many indicators to compare Verastem value to that of its competitors to determine the firm's financial worth.
Verastem is rated first in price to book category among its peers. It is rated fourth in ebitda category among its peers . Verastem reported last year EBITDA of (83.17 Million). Comparative valuation analysis is a catch-all technique that is used if you cannot value Verastem by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Verastem EBITDA vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Verastem

P/B

 = 

MV Per Share

BV Per Share

 = 
16.10 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Verastem

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(83.17 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Verastem EBITDA Comparison

Verastem is currently under evaluation in ebitda category among its peers.

Verastem Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Verastem, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Verastem will eventually generate negative long term returns. The profitability progress is the general direction of Verastem's change in net profit over the period of time. It can combine multiple indicators of Verastem, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income14.9 K15.7 K
Operating Income-92.1 M-96.7 M
Income Before Tax-87.4 M-91.7 M
Total Other Income Expense Net4.7 MM
Net Loss-87.4 M-91.7 M
Net Loss-76.8 M-80.6 M
Non Operating Income Net Other1.5 M1.4 M
Net Loss-66.4 M-69.8 M
Income Tax Expense-87.4 M-83 M
Net Interest Income1.4 M1.4 M
Interest Income5.1 M5.4 M
Change To Netincome5.4 M6.6 M
Net Loss(3.96)(4.16)
Income Quality 0.99  0.63 
Net Income Per E B T 1.15  1.18 

Verastem Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Verastem. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Verastem position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Verastem's important profitability drivers and their relationship over time.

Use Verastem in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Verastem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verastem will appreciate offsetting losses from the drop in the long position's value.

Verastem Pair Trading

Verastem Pair Trading Analysis

The ability to find closely correlated positions to Verastem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Verastem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Verastem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Verastem to buy it.
The correlation of Verastem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Verastem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Verastem moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Verastem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Verastem position

In addition to having Verastem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Healthcare Funds Thematic Idea Now

Healthcare Funds
Healthcare Funds Theme
Funds or Etfs investing in medical and healthcare goods or services as well as hospital management or maintenance organizations. The Healthcare Funds theme has 35 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Verastem is a strong investment it is important to analyze Verastem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Verastem's future performance. For an informed investment choice regarding Verastem Stock, refer to the following important reports:
Check out World Market Map.
To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
To fully project Verastem's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Verastem at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Verastem's income statement, its balance sheet, and the statement of cash flows.
Potential Verastem investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Verastem investors may work on each financial statement separately, they are all related. The changes in Verastem's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Verastem's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.